NCT07089992 2025-12-16A Study of Pembrolizumab in People With Ultra-Rare SarcomasMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting32 enrolled
NCT06277154 2025-07-24MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaHRYZ Biotech Co.Phase 2 Recruiting148 enrolled